FGFR2 and infantile convulsions and choreoathetosis: In approximately 3% of iCCA patients, FGFR2 insertions/deletions generate in-frame deletions in the extracellular domain (IED), which can impact ligand recognition and/or receptor dimerization and ultimately lead to FGFR2 oncogenic activation linked to iCCA pathogenesis.